On3 Recruits(@On3Recruits) 's Twitter Profile Photo

Following expert predictions from Sam Spiegelman and Gerry Hamilton, Texas Tech is trending to land Five-Star Plus+ WR Micah Hudson, according to the On3 Recruiting Prediction Machine📈

on3.com/db/expert-pred…

Following expert predictions from @samspiegs and @GHamilton_On3, Texas Tech is trending to land Five-Star Plus+ WR Micah Hudson, according to the On3 Recruiting Prediction Machine📈

on3.com/db/expert-pred…
account_circle
Juan Manuel Mejía(@Meyaix) 's Twitter Profile Photo

Results of the NefIgArd study presented at : budesonide slowed the rate of loss of eGFR & proteinuria in IgAN. Treatment for 9 months then suspended. After suspension, differences were maintained although eGFR decreased 4.59ml/min/y in the follow-up (vs 6.15 in ctrl group)

Results of the NefIgArd study presented at #ERA23: budesonide slowed the rate of loss of eGFR & proteinuria in IgAN. Treatment for 9 months then suspended. After suspension, differences were maintained although eGFR decreased 4.59ml/min/y in the follow-up (vs 6.15 in ctrl group)
account_circle
Usama Butt(@Dr_Usama_Butt) 's Twitter Profile Photo

SGLT2i led to 50% reduction in proteinurea at 12 months in C3 glomerulopathy.
Manuel Praga presenting C3G treatment strategies at

SGLT2i led to 50% reduction in proteinurea at 12 months in C3 glomerulopathy.
Manuel Praga presenting C3G treatment strategies at #ERA23
account_circle
Usama Butt(@Dr_Usama_Butt) 's Twitter Profile Photo

Shocking number of dialysis patient were found to have liver fibosis and significantly poor survival in advanced fibrosis, reported by Oscar Swift at .
Can GLP1 analogues break the curse ?
Enric Vilar Siva Sridharan Laura Ratcliffe

Shocking number of dialysis patient were found to have liver fibosis and significantly poor survival in advanced fibrosis, reported by @SwiftRenal at #ERA23.
Can GLP1 analogues break the curse ?
@EnricVilar @sayitmyway @lauraratcliffe7
account_circle